Remedent, Inc. Remedent, Inc.

Remedent, Inc.

REMI

Rank in Stocks #34331
Remedent, Inc., operating through its various subsidiaries, specializes in the... Remedent, Inc., operating through its various subsidiaries, specializes in the research, development, manufacturing, and distribution of products for both oral hygiene and aesthetic dentistry. The company's core offerings include professional-grade dental veneers and teeth whitening systems, designed for use by dental practitioners as well as for over-the-counter purchase by consumers. Its innovative product portfolio features River8, a pre-fabricated veneer solution that assists dentists in achieving optimal tooth alignment with minimal patient tooth reshaping. Additionally, Remedent supplies GlamSmile veneers, which are exceptionally thin shells bonded to the front surfaces of a patient's teeth. Beyond physical products, the company offers a suite of digital tools and services aimed at enhancing dental practice operations. These include the SmileMe Mirror, an integrated marketing concept that enables quick smile consultations in about ten minutes; SmileSketch, simulation software capable of creating visual previews of potential aesthetic results; and various "Treatment Pages" designed to explain the advantages of specific dental procedures. Furthermore, Remedent provides the Condor, an advanced intra-oral 3D scanning device. The company's expertise also extends to dental implant technologies and related treatment methodologies. Remedent distributes its products to dental professionals in nearly 30 countries, spanning regions such as Asia, Europe, the Middle East, Canada, and the United States, utilizing both its internal sales team and third-party distributors. Founded in 1986, the company's corporate headquarters are located in Ghent, Belgium.
Share Price
$0.0008
Last synced: 2026-11-10
Market Cap
$16.00K
Change (1 day)
0.00%
Change (1 year)
166.67%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Remedent, Inc. (REMI)
EPS as of March 2024 TTM: $-0.01
According to Remedent, Inc.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2024 the company had an EPS of $-0.01, an increase over its 2023 EPS of $-0.07.
EPS history for Remedent, Inc. from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.01 38.00%
2024 $-0.01 -81.68%
2023 $-0.07 479.84%
2022 $-0.01 57.32%
2021 $-0.01 -80.80%
2020 $-0.04 -138.82%
2019 $0.11 -4,028.57%
2018 0.00 -106.64%
2017 $0.04 427.50%
2016 $0.01 50.94%
2015 $0.01 -79.77%
2014 $0.03 -153.36%
2013 $-0.05 -300.41%
2012 $0.02 -131.65%
2011 $-0.08 -35.50%
2010 $-0.12 -20.00%
2009 $-0.15 -11.76%
2008 $-0.17 41.67%
2007 $-0.12 -65.71%
2006 $-0.35 593.07%
2005 $-0.05 152.50%
2004 $-0.02 -96.92%
2003 $-0.65 -70.18%
2002 $-2.18 83.19%
2001 $-1.19 -17.93%
2000 $-1.45 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$8.37 -60,752.17%
US
$5.95 -43,235.51%
FR
$4.15 -30,172.46%
US
$5.26 -38,211.59%
JP
$1.34 -9,810.14%
CH

Questions about Remedent, Inc.'s earnings per share (EPS)

What is Remedent, Inc.'s earnings per share (EPS)?

Remedent, Inc.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Mar 2024.

What was Remedent, Inc.'s earnings per share (EPS) in 2024?

In 2024, Remedent, Inc.'s earnings per share (EPS) was $-0.01, compared with $-0.07 in 2023.

How has Remedent, Inc.'s earnings per share (EPS) changed since 2019?

From 2019 to 2024, Remedent, Inc.'s earnings per share (EPS) was highest in 2019 ($0.11) and lowest in 2023 ($-0.07).

How does Remedent, Inc.'s earnings per share (EPS) compare with similar companies?

Remedent, Inc.'s earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.